Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2008; 18(03): 249-255
DOI: 10.4103/0971-3026.41840
Interventional Radiology Symposium

Interventional radiology in the management of portal hypertension

Sundeep J Punamiya
Department of Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore 308433
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

From being a mere (though important) diagnostic tool, radiology has evolved to become an integral part of therapy in portal hypertension today. Various procedures are currently available, the choice depending on the etiology and location of disease, the pathoanatomy, and the symptomatology. The main aim of any procedure is to reduce the portal pressure by either direct or indirect methods. This can be achieved with transjugular intrahepatic portosystemic shunt (TIPS), recanalization of the hepatic vein outflow, recanalization of the portal vein and its tributaries, recanalization of dysfunctional portosystemic shunts, partial splenic embolization, and embolization of arterioportal shunts. When any of these procedures cannot be performed due to anatomical or physiological reasons, the symptoms can often be controlled effectively with embolization of varices or balloon-occluded retrograde transvenous obliteration of varices (BRTO). This article briefly describes the procedures, their results, and their current status in the treatment of portal hypertension.

Keywords

Interventional radiology - portal hypertension


Publication History

Article published online:
31 July 2021

© 2008. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Rφsch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: An experimental study. Radiology 1969;92:1112-4.
  • 2 Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases practice guidelines: The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386-400.
  • 3 Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: Current status. J Vasc Interv Radiol 2005;16:449-55.
  • 4 Cabrera J, Manyar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al . Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-9.
  • 5 Rossle M, Deibert P, Haag K, Ochs A, Olchewski M, Siegerstetter V, et al . Randomised trial of transjugular intrahepatic portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;249:1043-9.
  • 6 Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent versus sclerotherapy plus propranolol for rebleeding. Gastroenterology 1997;113:1623-31.
  • 7 Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3 rd , -Shiffman ML, Cole PE, et al . Transjugular intrahepatic portosystemic shunt -compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial. Ann Intern Med 1997;126:849-57.
  • 8 Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, et al . Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: A randomized, controlled trial. Ann Int Med 1997;126:858-65.
  • 9 Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26:1115.
  • 10 Merli M, Salerno F, Riggio O, deFranchis R, Fiaccadori F, Meddi P, et al . Transjugular intrahepatic portosystemic shunt versus -endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial. Gruppo Italiano Studio TIPS (GIST). Hepatology 1998;27:48-53.
  • 11 Groupe d′Etude des Anastomoses Intra-Hepatiques. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: Preliminary results of a multicenter randomized trial. -Hepatology 1995;22:A297.
  • 12 Garcia-Villareal L, Martinez-Lagares F, Sierra A, Guevera C, -Marrero JM, Jiminez E, et al . Transjugular intrahepatic portosystemic shunt versus sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999:29:27-32.
  • 13 Sauer P, Benz C, Thielmann L, Richter G, Stermmel W, Stiehl A. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs endoscopic banding in the prevention of variceal rebleeding: Final results of a randomized study. Gastroenterology 1998;114:A1334.
  • 14 Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, -Perrault P, Fenyves D, et al . Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: A randomized trial. Gut 2001;48:390-6.
  • 15 Narahara Y, Kanawaza H, Kawamata H, Tada N, Saitoh H, -Matsuzaka S, et al . A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 2001;21:189-98.
  • 16 Gulberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggerhauser T, et al . Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: A randomized controlled trial. Scand J Gastroenterol 2002;37:338-43.
  • 17 Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al . A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-7.
  • 18 Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al . Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-47.
  • 19 Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al . The North American study for the treatment of refractory ascites. Gastroenterology 2003;124:634-41.
  • 20 Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al . Randomized control study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004;40:629-35.
  • 21 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: Long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001;13:529-34.
  • 22 Middleton WD, Teefey SA, Darcy MD. Doppler evaluation of transjugular intrahepatic portosystemic shunts. Ultrasound Q 2003;19:56-70.
  • 23 Hausegger KA, Kernel F, Georgieva B, et al . Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroehthylene-covered stent-graft. J Vasc Interv Radiol 2004;15:239-48.
  • 24 Rossi P, Salvatori FM, Fanelli F, Bezzi M, Rossi M, Marcelli G. Polytetrafluoroethylene covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004;231:820-30.
  • 25 Bureau C, Garcia-Pagan JC, Pomier-Layrargues G, Metivier S, Otal P, Perreault P, et al . A randomized study comparing the use of polytetrafluoroethane (PTFE) covered stents and uncovered stents for TIPS: Long term patency. Hepatology 2004;40:186A.
  • 26 Maleux G, Verslype C, Heye S, Wilms G, Marchal G, Nevens F. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: Preliminary experience with reduction stents and stent-grafts. Am J Roentgenol 2007;188:659-64.
  • 27 Qiaoa T, Liua CJ, Liua C, Chena K, Zhanga XB, Zub MH. Interventional endovascular treatment of Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly 2005;135:318-26.
  • 28 Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: Outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
  • 29 Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, et al . Budd-Chiari syndrome: Long term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2005;20:1494-502.
  • 30 Yamakado K, Nakatsuka A, Tanaka N, Fujii A, Isaji S, Kawarada Y, et al . Portal venous stent placement in patients with pancreatic and biliary neoplasms invading portal veins and causing portal hypertension: Initial experience. Radiology 2001;220:150-6.
  • 31 Shan H, Xiao XS, Huang MS, Ouyang Q, Jiang ZB. Portal venous stent placement for treatment of portal hypertension caused by benign main portal vein stenosis. World J Gastroenterol 2005;11:3315-8.
  • 32 Vauthey JN, Tomczak RJ, Helmberger T, Gertsch P, Forsmark C, Caridi J, et al . The arterioportal fistula syndrome: Clinicopathologic features, diagnosis and therapy. Gastroenterology 1997;113:1390-401.
  • 33 Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: A review of the English language literature. J Vasc Interv Radiol 2007;18:463-81.
  • 34 Lunderquist A, Simert G, Tylen U, Vang J. Follow-up of patients with portal hypertension and esophageal varices treated with percutaneous obliteration of gastric coronary vein. Radiology 1977;122:59-63.
  • 35 L′Hermine C, Chastanet P, Delemazure O, Bonniere PL, Durieu JP, Paris JC. Percutaneous transhepatic embolization of gastroesophageal varices: Results in 400 patients. Am J Roentgenol 1989;152:755-60.
  • 36 Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. -Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: Its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003;4:109-16.
  • 37 Ninoi T, Nishida N, Kaminou T, Sakai Y, Kitayama T, Hamuro M, et al . Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: Long-term follow-up in 78 patients. Am J Roentgenol 2005;184:1340-6.
  • 38 Park JS, Jong YW, Park SI, Park SJ, Lee DY. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. J Vasc Interv Radiol 2001;12:1445-8.